Skip to Main Content

Paper Details

Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoforms.
Future Oncol
5
2021
5C11-2, AML, AML cell lines, CD33, CD33 antibodies, CD33 isoforms, CD33D2, CD33D2 isoform, CD33D2 isoforms, CD33FL, HL2541, IgC domain, IgC-targeting antibodies, acute myeloid leukemia (AML), anti-CD33D2, primary AML specimens, primary AML/progenitor cells, unmodified, unmodified acute myeloid leukemia (AML) cell lines
Author NameAffiliation
Christopher R CogleCollege of Medicine, University of Florida
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
  • 1 - 3

Datasets

Release 1.2